論文

査読有り 国際誌
2017年3月

Circulating tricarboxylic acid cycle metabolite levels in citrin-deficient children with metabolic adaptation, with and without sodium pyruvate treatment.

Molecular genetics and metabolism
  • Hironori Nagasaka
  • Haruki Komatsu
  • Ayano Inui
  • Mariko Nakacho
  • Ichiro Morioka
  • Hirokazu Tsukahara
  • Shunsaku Kaji
  • Satoshi Hirayama
  • Takashi Miida
  • Hiroki Kondou
  • Kenji Ihara
  • Mariko Yagi
  • Zenro Kizaki
  • Kazuhiko Bessho
  • Takahiro Kodama
  • Kazumoto Iijima
  • Takeyori Saheki
  • Tohru Yorifuji
  • Akira Honda
  • 全て表示

120
3
開始ページ
207
終了ページ
212
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.ymgme.2016.12.011
出版者・発行元
ACADEMIC PRESS INC ELSEVIER SCIENCE

Citrin deficiency causes adult-onset type II citrullinemia (CTLN-2), which later manifests as severe liver steatosis and life-threatening encephalopathy. Long-standing energy deficit of the liver and brain may predispose ones to CTLN-2. Here, we compared the energy-driving tricarboxylic acid (TCA) cycle and fatty acid beta-oxidation cycle between 22 citrin-deficient children (age, 3-13 years) with normal liver functions and 37 healthy controls (age, 5-13 years). TCA cycle analysis showed that basal plasma citrate and alpha-ketoglutarate levels were significantly higher in the affected than the control group (p < 0.01). Conversely, basal plasma fumarate and malate levels were significantly lower than those for the control (p < 0.001). The plasma level of 3-OH-butyrate derived from fatty acid (3-oxidation was significantly higher in the affected group (p < 0.01). Ten patients underwent sodium pyruvate therapy. However, this therapy did not correct or attenuate such deviations in both cycles. Sodium pyruvate therapy significantly increased fasting insulin secretion (p < 0.01); the fasting sugar level remained unchanged. Our results suggest that citrin-deficient children show considerable deviations of TCA cycle metabolite profiles that are resistant to sodium pyruvate treatment. Thus, long-standing and considerable TCA cycle dysfunction might be a pivotal metabolic background of CTLN-2 development. (C) 2016 Elsevier Inc. All rights reserved.

リンク情報
DOI
https://doi.org/10.1016/j.ymgme.2016.12.011
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/28041819
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000397080600006&DestApp=WOS_CPL
ID情報
  • DOI : 10.1016/j.ymgme.2016.12.011
  • ISSN : 1096-7192
  • eISSN : 1096-7206
  • PubMed ID : 28041819
  • Web of Science ID : WOS:000397080600006

エクスポート
BibTeX RIS